Invitae Corp provides genetic testing services that screen for a variety of conditions, including cardiovascular, neurology, and pediatric disorders, hereditary cancer, and rare diseases. The firm consolidates several genetic tests into a single offering, which is often sold at a lower prices than other single- or multi-gene panels. Invitae typically charges one price per indication, regardless of the number of genes tested. It also offers full gene sequencing and deletion and duplication analysis for its tests. Invitae currently markets its test to medical geneticists and genetic counselors. The majority of Invitae’s revenue is generated in the United States.